Market Cap (In KRW)
318.96 Billion
Revenue (In KRW)
1.1 Billion
Net Income (In KRW)
-42.34 Billion
Avg. Volume
62.36 Thousand
- Currency
- KRW
- Country
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 36100.0-110000.0
- PE
- -
- EPS
- -
- Beta Value
- 1.757
- ISIN
- KR7199800004
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Industry
- CEO
- Mr. Young Ho Kim
- Employee Count
- -
- Website
- https://www.toolgen.com
- Ipo Date
- 2017-04-05
- Details
- ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses. ToolGen Incorporated was founded in 1999 and is based in Seoul, South Korea.
More Stocks
-
EFGSFEiffage SA
EFGSF
-
1750
-
DKNGDraftKings Inc.
DKNG
-
KFR
-
SWADPOLSwadeshi Polytex Limited
SWADPOL
-
MOHCF
-
ALKKOKKO International SA
ALKKO
-
323990